Cyclooxygenase-2 inhibition and cardiovascular events

被引：72

作者：

Pitt, B

Pepine, C

Willerson, JT

机构：

[1] Univ Texas, Hlth Sci Ctr, St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA

[2] Univ Florida, Sch Med, Gainesville, FL USA

[3] Univ Michigan, Sch Med, Ann Arbor, MI USA

来源：

CIRCULATION | 2002年 / 106卷 / 02期

关键词：

editorials; drugs; cardiovascular disease;

D O I：

10.1161/01.CIR.0000025261.58465.62

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：167 / 169

页数：3

共 24 条

[1] Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation - The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study
Altman, R
Luciardi, HL
Muntaner, J
Del Rio, F
Berman, SG
Lopez, R
Gonzalez, C
[J]. CIRCULATION, 2002, 106 (02) : 191 - 195
[2] Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages
Baker, CSR
Hall, RJC
Evans, TJ
Pomerance, A
Maclouf, J
Creminon, C
Yacoub, MH
Polak, JM
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) : 646 - 655
[3] NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection
Boers, M
[J]. LANCET, 2001, 357 (9264) : 1222 - 1223
[4] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Day, R
Ferraz, MB
Hawkey, CJ
Hochberg, MC
Kvien, TK
Schnitzer, TJ
Weaver, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
[5] Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
Burleigh, ME
Babaev, VR
Oates, JA
Harris, RC
Gautam, S
Riendeau, D
Marnett, LJ
Morrow, JD
Fazio, S
Linton, MF
[J]. CIRCULATION, 2002, 105 (15) : 1816 - 1823
[6] Catella-Lawson Francesca, 2001, American Journal of Medicine, V110, p28S
[7] Role of prostacyclin in the cardiovascular response to thromboxane A2
Cheng, Y
Austin, SC
Rocca, B
Koller, BH
Coffman, TM
Grosser, T
Lawson, JA
FitzGerald, GA
[J]. SCIENCE, 2002, 296 (5567) : 539 - 541
[8] Crofford LJ, 2000, ARTHRITIS RHEUM, V43, P1891, DOI 10.1002/1529-0131(200008)43:8<1891::AID-ANR28>3.0.CO
[9] 2-R
[10] Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries
Hennan, JK
Huang, JB
Barrett, TD
Driscoll, EM
Willens, DE
Park, AM
Crofford, LJ
Lucchesi, BR
[J]. CIRCULATION, 2001, 104 (07) : 820 - 825

← 1 2 3 →